Pan YM - Search Results

1

STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.

Pan YM, Wang CG, Zhu M, Xing R, Cui JT, Li WM, Yu DD, Wang SB, Zhu W, Ye YJ, Wu Y, Wang S, Lu YY. Pan YM, et al. Mol Cancer. 2016 Dec 9;15(1):79. doi: 10.1186/s12943-016-0561-z. Mol Cancer. 2016. PMID: 27938379 Free PMC article.

2

Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis.

Xu HY, Chen ZW, Pan YM, Fan L, Guan J, Lu YY. Xu HY, et al. Among authors: pan ym. Dig Dis Sci. 2012 Jul;57(7):1847-56. doi: 10.1007/s10620-012-2090-y. Epub 2012 Feb 23. Dig Dis Sci. 2012. PMID: 22359193

3

12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.

Xu HY, Pan YM, Chen ZW, Lin Y, Wang LH, Chen YH, Jie TT, Lu YY, Liu JC. Xu HY, et al. Among authors: pan ym. J Ethnopharmacol. 2013 Apr 19;146(3):724-33. doi: 10.1016/j.jep.2013.01.007. Epub 2013 Feb 19. J Ethnopharmacol. 2013. PMID: 23434607

4

MiR-23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells.

An J, Pan Y, Yan Z, Li W, Cui J, Yuan J, Tian L, Xing R, Lu Y. An J, et al. J Cell Biochem. 2013 Sep;114(9):2160-9. doi: 10.1002/jcb.24565. J Cell Biochem. 2013. PMID: 23553990

5

MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.

Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY. Li DM, et al. Among authors: pan ym. World J Gastroenterol. 2013 May 14;19(18):2781-92. doi: 10.3748/wjg.v19.i18.2781. World J Gastroenterol. 2013. PMID: 23687415 Free PMC article.

6

Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.

Pan Y, Huang J, Xing R, Yin X, Cui J, Li W, Yu J, Lu Y. Pan Y, et al. J Transl Med. 2013 Jul 19;11:173. doi: 10.1186/1479-5876-11-173. J Transl Med. 2013. PMID: 23870553 Free PMC article.

7

Clinicopathological significance of altered metallothionein 2A expression in gastric cancer according to Lauren's classification.

Pan YM, Xing R, Cui JT, Li WM, Lü YY. Pan YM, et al. Chin Med J (Engl). 2013 Jul;126(14):2681-6. Chin Med J (Engl). 2013. PMID: 23876896

8

Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.

Li H, Wang J, Xu H, Xing R, Pan Y, Li W, Cui J, Zhang H, Lu Y. Li H, et al. Mol Cancer. 2013 Sep 25;12(1):110. doi: 10.1186/1476-4598-12-110. Mol Cancer. 2013. PMID: 24063558 Free PMC article.

9

Identification of gene signatures used to recognize biological characteristics of gastric cancer upon gene expression data.

Yan Z, Luke BT, Tsang SX, Xing R, Pan Y, Liu Y, Wang J, Geng T, Li J, Lu Y. Yan Z, et al. Biomark Insights. 2014 Aug 14;9:67-76. doi: 10.4137/BMI.S13059. eCollection 2014. Biomark Insights. 2014. PMID: 25210421 Free PMC article.

10

Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1.

Pan Y, Wang L, Kang SG, Lu Y, Yang Z, Huynh T, Chen C, Zhou R, Guo M, Zhao Y. Pan Y, et al. ACS Nano. 2015 Jul 28;9(7):6826-36. doi: 10.1021/nn506782f. Epub 2015 Jun 22. ACS Nano. 2015. PMID: 26083726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters